BONH
BBNX

Bank of New Hampshire’s Beta Bionics BBNX Stock Holding History

Bank of New Hampshire’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-680
Closed -$20.7K – 569
2025
Q4 		$20.7K Hold
680
– – ﹤0.01% 360
2025
Q3 		$13.5K Hold
680
– – ﹤0.01% 385
2025
Q2 		$9.9K Buy
+680
New +$9.63K ﹤0.01% 408

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of New Hampshire's BBNX Position: Q1 2026 in Review

Bank of New Hampshire sold out of Beta Bionics (BBNX) in Q1 2026, closing a stake of 680 shares — an estimated $20.7K sold.

Bank of New Hampshire first reported a position in BBNX in Q2 2025 and held it in 3 quarters. The position peaked at $20.7K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Bank of New Hampshire reported no remaining Beta Bionics position as of Q1 2026 after selling out during the quarter.
  • Bank of New Hampshire sold 680 Beta Bionics shares in Q1 2026, an estimated $20.7K.
  • Bank of New Hampshire first reported a position in Beta Bionics in Q2 2025 and held it in 3 quarters.
  • Bank of New Hampshire's Beta Bionics position peaked at $20.7K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Bank of New Hampshire's 13F filing for Q1 2026, filed 13 Apr 2026.